Literature DB >> 1532926

Liver-infiltrating T helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialoglycoprotein receptor in vitro.

H Löhr1, U Treichel, T Poralla, M Manns, K H Meyer zum Büschenfelde.   

Abstract

Autoantibodies against the human asialoglycoprotein receptor (ASGPR) occur in the sera of patients with autoimmune liver disorders. Liver-infiltrating T cell clones that specifically recognize the ASGPR have been described in patients with autoimmune chronic active hepatitis (AI-CAH) and primary biliary cirrhosis (PBC). Recently, we have shown that peripheral blood mononuclear cells (PBMC) from patients with AI-CAH or PBC but not chronic viral hepatitis secreted anti-ASGPR antibodies in vitro. In this study we characterized the influence of liver-infiltrating T cells on the secretion of ASGPR-specific autoantibodies by autologous B cells in cell culture supernatants. T cell clones from liver biopsies of three patients with chronic autoimmune liver disorders (one with AI-CAH, two with PBC) were isolated and investigated for their proliferative response to soluble ASGPR and their helper function provided to autoantibody-secreting B lymphocytes. PBMC from these patients secreted autoantibodies spontaneously in their cell culture supernatants and showed a proliferative response to ASGPR. T cell-depleted PBMC, however, lacked spontaneous antibody secretion. Four CD4+CD8- liver-infiltrating T cell clones showed a proliferative response to ASGPR and also induced spontaneous anti-ASGPR antibody production in cell culture supernatants when added to autologous T cell depleted PBMC. Activated supernatants of these T cell clones failed to induce antibody production. None of seven CD4+CD8- and two CD4-CD8+ T cell clones non-responding to ASGPR provided this help for antibody secretion. Anti-ASGPR secretion in vitro could not be inhibited by the addition of MoAbs raised against monomorphic determinants on HLA class II molecules. The addition of purified ASGPR or polyclonal-activating pokeweed mitogen showed no influence on the production of autoantibodies in these cultures. These data show that B lymphocytes require T cell help for the production of ASGPR-specific antibodies. This help can be provided by ASGPR-responsive T helper cells via cellular interactions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1532926      PMCID: PMC1554373          DOI: 10.1111/j.1365-2249.1992.tb03037.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Cognate interactions between helper T cells and B cells. V. Reconstitution of T helper cell function using purified plasma membranes from activated Th1 and Th2 T helper cells and lymphokines.

Authors:  R J Noelle; J Daum; W C Bartlett; J McCann; D M Shepherd
Journal:  J Immunol       Date:  1991-02-15       Impact factor: 5.422

2.  Class I and class II major histocompatibility complex antigen expression on hepatocytes: a study in children with liver disease.

Authors:  A Lobo-Yeo; G Senaldi; B Portmann; A P Mowat; G Mieli-Vergani; D Vergani
Journal:  Hepatology       Date:  1990-08       Impact factor: 17.425

3.  HLA-A,B,C, HLA-D/DR and HLA-D/DQ expression on unfixed liver biopsy sections from patients with chronic liver disease.

Authors:  G Ballardini; F B Bianchi; R Mirakian; M Fallani; E Pisi; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

4.  Immunohistochemical localization of human liver specific protein using rabbit antisera and the avidin-biotin complex technique.

Authors:  H Helin; R Uibo; I Paronen; K Krohn
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

5.  A beta-galactosidase linked immunoassay for the analysis of antigens on individual cells.

Authors:  B Holzmann; J P Johnson
Journal:  J Immunol Methods       Date:  1983-06-10       Impact factor: 2.303

6.  Cognate interactions between helper T cells and B cells. III. Contact-dependent, lymphokine-independent induction of B cell cycle entry by activated helper T cells.

Authors:  R J Noelle; J McCann; L Marshall; W C Bartlett
Journal:  J Immunol       Date:  1989-09-15       Impact factor: 5.422

7.  The human hepatic asialoglycoprotein receptor is a target antigen for liver-infiltrating T cells in autoimmune chronic active hepatitis and primary biliary cirrhosis.

Authors:  H Löhr; U Treichel; T Poralla; M Manns; K H Meyer zum Büschenfelde; B Fleischer
Journal:  Hepatology       Date:  1990-12       Impact factor: 17.425

8.  Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis.

Authors:  U Treichel; T Poralla; G Hess; M Manns; K H Meyer zum Büschenfelde
Journal:  Hepatology       Date:  1990-04       Impact factor: 17.425

9.  Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.

Authors:  H F Eggink; H J Houthoff; S Huitema; C H Gips; S Poppema
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

Review 10.  Autoantibodies and antigens in liver diseases--updated.

Authors:  M Manns
Journal:  J Hepatol       Date:  1989-09       Impact factor: 25.083

View more
  13 in total

Review 1.  Autoantibodies as prognostic markers in autoimmune liver disease.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-05-13       Impact factor: 3.199

Review 2.  Juvenile autoimmune hepatitis: Spectrum of the disease.

Authors:  Giuseppe Maggiore; Silvia Nastasio; Marco Sciveres
Journal:  World J Hepatol       Date:  2014-07-27

Review 3.  Cutting edge issues in autoimmune hepatitis.

Authors:  Diego Vergani; Giorgina Mieli-Vergani
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

Review 4.  Autoantibody-negative autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-12-21       Impact factor: 3.199

Review 5.  Autoimmune hepatitis.

Authors:  Giorgina Mieli-Vergani; Diego Vergani
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-05-03       Impact factor: 46.802

Review 6.  Autoimmune hepatitis. Definition--classification--histopathology--immunopathogenesis.

Authors:  K H Meyer zum Büschenfelde; H P Dienes
Journal:  Virchows Arch       Date:  1996-09       Impact factor: 4.064

7.  Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis.

Authors:  Zhidan Tu; Qing Li; Hong-Shiue Chou; Ching-Chuang Hsieh; Howard Meyerson; Marion G Peters; Hong Bu; John J Fung; Shiguang Qian; Lina Lu; Feng Lin
Journal:  Immunobiology       Date:  2010-08-19       Impact factor: 3.144

8.  Analysis of the in vitro cytokine production by liver-infiltrating T cells of patients with autoimmune hepatitis.

Authors:  J F Schlaak; H Löhr; H Gallati; K H Meyer zum Büschenfelde; B Fleischer
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

Review 9.  Autoimmune hepatitis.

Authors:  Diego Vergani; Maria Serena Longhi; Dimitrios P Bogdanos; Yun Ma; Giorgina Mieli-Vergani
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

Review 10.  Aetiopathogenesis of autoimmune hepatitis.

Authors:  Diego Vergani; Giorgina Mieli-Vergani
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.